ArticleRoyal Society open science2020

Targeting the glycan of receptor binding domain with jacalin as a novel approach to develop a treatment against COVID-19.

Senthilnathan Rajendaran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.